GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Shree Ganesh Biotech (India) Ltd (BOM:539470) » Definitions » Cash Ratio

Shree Ganesh Biotech (India) (BOM:539470) Cash Ratio : 0.00 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Shree Ganesh Biotech (India) Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Shree Ganesh Biotech (India)'s Cash Ratio for the quarter that ended in Dec. 2023 was 0.00.

Shree Ganesh Biotech (India) has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Shree Ganesh Biotech (India)'s Cash Ratio or its related term are showing as below:

BOM:539470' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.03   Max: 0.36
Current: 0.01

During the past 9 years, Shree Ganesh Biotech (India)'s highest Cash Ratio was 0.36. The lowest was 0.01. And the median was 0.03.

BOM:539470's Cash Ratio is ranked worse than
97.11% of 242 companies
in the Agriculture industry
Industry Median: 0.325 vs BOM:539470: 0.01

Shree Ganesh Biotech (India) Cash Ratio Historical Data

The historical data trend for Shree Ganesh Biotech (India)'s Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shree Ganesh Biotech (India) Cash Ratio Chart

Shree Ganesh Biotech (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only 0.01 - - - 0.03

Shree Ganesh Biotech (India) Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 - 0.01 -

Competitive Comparison of Shree Ganesh Biotech (India)'s Cash Ratio

For the Agricultural Inputs subindustry, Shree Ganesh Biotech (India)'s Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shree Ganesh Biotech (India)'s Cash Ratio Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Shree Ganesh Biotech (India)'s Cash Ratio distribution charts can be found below:

* The bar in red indicates where Shree Ganesh Biotech (India)'s Cash Ratio falls into.



Shree Ganesh Biotech (India) Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Shree Ganesh Biotech (India)'s Cash Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

Cash Ratio (A: Mar. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=4.802/171.661
=0.03

Shree Ganesh Biotech (India)'s Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shree Ganesh Biotech (India)  (BOM:539470) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Shree Ganesh Biotech (India) Cash Ratio Related Terms

Thank you for viewing the detailed overview of Shree Ganesh Biotech (India)'s Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shree Ganesh Biotech (India) (BOM:539470) Business Description

Traded in Other Exchanges
N/A
Address
CUBICLE NO.:126,3/2 ,75C,PARK STREET, 3RD FLOOR, KAMDHENU BUILDING, Kolkata, WB, IND, 700016
Shree Ganesh Biotech (India) Ltd is an India based company mainly engaged in the trading of seeds. It is engaged in the business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum.

Shree Ganesh Biotech (India) (BOM:539470) Headlines

No Headlines